Alere Inc. develops and manufactures patient diagnosis, monitoring, and health management products and services for cardiology, infectious diseases, toxicology, diabetes, oncology, and women’s health in the United States and internationally. The company’s Professional Diagnostics segment provides an array of diagnostic test and other in vitro diagnostic test products to medical professionals and laboratories for detection of diseases and conditions. This segment also sells blood analysis system for blood gas and electrolyte testing; and disposable and lateral flow rapid diagnostic tests. Its Health Management segment provides integrated programs and services focused on wellness, disease and condition management, productivity enhancement, and informatics. This segment’s health management programs comprise disease and case management, patient self-testing, women’s and children’s health, and oncology programs, as well a wellness and technology solutions. The company’s Consumer Diagnostics segment offers over-the-counter pregnancy and fertility/ovulation test products; over-the-counter drug tests for at-home-testing; over-the-counter tests for cholesterol monitoring and colon cancer screening; and vaginal gel for the treatment of bacterial vaginosis without antibiotics. Alere Inc. markets its professional diagnostic products to hospitals, reference laboratories, physician offices, and other point-of-care settings through its sales forces and distribution networks; health management programs primarily to commercial and governmental health plans, self-insured employers, pharmaceutical companies, and physicians through sales force and channel partners; and consumer drug testing products through retail drug stores, drug wholesalers, groceries, and mass merchandisers. The company was formerly known as Inverness Medical Innovations, Inc. and changed its name to Alere Inc. in July 2010. Alere Inc. was founded in 2001 and is headquartered in Waltham, Massachusetts.